Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis.

Dörr S, Lechtenböhmer N, Rau R, Herborn G, Wagner U, Müller-Myhsok B, Hansmann I, Keyszer G.

Arthritis Res Ther. 2004;6(3):R199-207. Epub 2004 Mar 8.

2.

Variation of matrix metalloproteinase 1 and 3 haplotypes and their serum levels in patients with rheumatoid arthritis and osteoarthritis.

Abd-Allah SH, Shalaby SM, Pasha HF, El-Shal AS, Abou El-Saoud AM.

Genet Test Mol Biomarkers. 2012 Jan;16(1):15-20. doi: 10.1089/gtmb.2011.0003. Epub 2011 Jul 19.

PMID:
21770773
3.

Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.

Zinzindohoué F, Blons H, Hans S, Loriot MA, Houllier AM, Brasnu D, Laccourreye O, Tregouet DA, Stucker I, Laurent-Puig P.

Anticancer Res. 2004 May-Jun;24(3b):2021-6.

4.

Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.

Hirata H, Okayama N, Naito K, Inoue R, Yoshihiro S, Matsuyama H, Suehiro Y, Hamanaka Y, Hinoda Y.

Carcinogenesis. 2004 Dec;25(12):2379-84. Epub 2004 Aug 19.

PMID:
15319295
5.

Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis.

Bradbury PA, Zhai R, Hopkins J, Kulke MH, Heist RS, Singh S, Zhou W, Ma C, Xu W, Asomaning K, Ter-Minassian M, Wang Z, Su L, Christiani DC, Liu G.

Carcinogenesis. 2009 May;30(5):793-8. doi: 10.1093/carcin/bgp065. Epub 2009 Mar 25.

6.

The function of the SNP in the MMP1 and MMP3 promoter in susceptibility to endometriosis in China.

Shan K, Ying W, Jian-Hui Z, Wei G, Na W, Yan L.

Mol Hum Reprod. 2005 Jun;11(6):423-7. Epub 2005 May 6.

PMID:
15879464
7.

Variations in matrix metalloproteinase-1, -3, and -9 genes and the risk of acute coronary syndrome and coronary artery disease in the Chinese Han population.

Xu X, Wang L, Xu C, Zhang P, Yong F, Liu H, Wang J, Shi Y.

Coron Artery Dis. 2013 Jun;24(4):259-65. doi: 10.1097/MCA.0b013e32835ea3af.

PMID:
23377317
8.

Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.

Fang S, Jin X, Wang R, Li Y, Guo W, Wang N, Wang Y, Wen D, Wei L, Zhang J.

Carcinogenesis. 2005 Feb;26(2):481-6. Epub 2004 Nov 4.

PMID:
15528217
9.

Matrix metalloproteinase 1, 3, and 9 polymorphisms and esophageal squamous cell carcinoma risk.

Guan X, Wang X, Luo H, Wu J, Zhang X, Wu J.

Med Sci Monit. 2014 Nov 13;20:2269-74. doi: 10.12659/MSM.892413.

10.

Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population.

Astolfi CM, Shinohara AL, da Silva RA, Santos MC, Line SR, de Souza AP.

J Clin Periodontol. 2006 Oct;33(10):699-703. Epub 2006 Aug 7.

PMID:
16899023
11.

Association of Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Gene Variants with Ischemic Stroke and Its Subtype.

Huang XY, Han LY, Huang XD, Guan CH, Mao XL, Ye ZS.

J Stroke Cerebrovasc Dis. 2017 Feb;26(2):368-375. doi: 10.1016/j.jstrokecerebrovasdis.2016.09.034. Epub 2016 Oct 25.

PMID:
27793533
12.

Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis.

Mattey DL, Nixon NB, Dawes PT, Ollier WE, Hajeer AH.

Genes Immun. 2004 Mar;5(2):147-9.

PMID:
14712311
13.

Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.

Peng B, Cao L, Wang W, Xian L, Jiang D, Zhao J, Zhang Z, Wang X, Yu L.

Mutagenesis. 2010 Jan;25(1):41-8. doi: 10.1093/mutage/gep041. Epub 2009 Oct 20.

PMID:
19843588
14.

Influence of variations across the MMP-1 and -3 genes on the serum levels of MMP-1 and -3 and disease activity in rheumatoid arthritis.

Chen Y, Nixon NB, Dawes PT, Mattey DL.

Genes Immun. 2012 Jan;13(1):29-37. doi: 10.1038/gene.2011.46. Epub 2011 Jul 14.

PMID:
21753786
15.

Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: Association with severity and progression of rheumatoid arthritis in a prospective study.

Constantin A, Lauwers-Cancès V, Navaux F, Abbal M, van Meerwijk J, Mazières B, Cambon-Thomsen A, Cantagrel A.

Arthritis Rheum. 2002 Jul;46(7):1754-62.

16.

Matrix metalloproteinase gene polymorphisms in patients with rheumatoid arthritis.

Scherer S, de Souza TB, de Paoli J, Brenol CV, Xavier RM, Brenol JC, Chies JA, Simon D.

Rheumatol Int. 2010 Jan;30(3):369-73. doi: 10.1007/s00296-009-0974-8. Epub 2009 Jun 6.

PMID:
19504098
17.

Association of the 5A/6A promoter polymorphism of the MMP-3 gene with the radiographic progression of rheumatoid arthritis.

Nemec P, Pavkova-Goldbergova M, Gatterova J, Vasku A, Soucek M.

Ann N Y Acad Sci. 2007 Sep;1110:166-76.

PMID:
17911432
18.

[Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].

Kang S, Wang Y, Zhang JH, Jin X, Fang SM, Li Y.

Zhonghua Fu Chan Ke Za Zhi. 2005 Sep;40(9):601-4. Chinese.

PMID:
16202315
19.

Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China.

Lu Z, Cao Y, Wang Y, Zhang Q, Zhang X, Wang S, Li Y, Xie H, Jiao B, Zhang J.

J Neurooncol. 2007 Oct;85(1):65-73. Epub 2007 May 15.

PMID:
17502998
20.

Matrix metalloproteinase gene polymorphisms and susceptibility to systemic sclerosis.

Rech TF, Moraes SB, Bredemeier M, de Paoli J, Brenol JC, Xavier RM, Chies JA, Simon D.

Genet Mol Res. 2016 Dec 19;15(4). doi: 10.4238/gmr15049077.

PMID:
28002595

Supplemental Content

Support Center